Nov 5, 2010 | Laboratory News, Laboratory Pathology, News From Dark Daily
Goal is for medical laboratories to enhance patient’s phlebotomy experience
DATELINE: San Antonio, Texas—Here in the Alamo City this week, many of the nation’s most innovative clinical laboratories, pathology groups, and in vitro diagnostics manufacturers came together to share their successes in the use of Lean, Six Sigma, and similar process improvement techniques.
The occasion was the Fourth Annual Lab Quality Confab and Performance Improvement Institute. This high-energy event was notable for several reasons. First, despite a lackluster economy, attendance was up more than 20% over last year. When asked about their participation, many attendees said that their parent hospital or health system sent them to the Lab Quality Confab specifically to bring back ideas for quality improvement projects that would advance clinical care while taking costs out of laboratory operations.
More Medical Laboratories Now Use Lean and Six Sigma Methods
(more…)
Sep 14, 2010 | Instruments & Equipment, Laboratory News, Laboratory Pathology
Industrial engineering firm issues “Consumer Report”-type assessment of mid-volume, automated IA and ID analyzer systems
It’s not often that pathologists and clinical laboratory managers can access a Consumer Reports-type of comparison of laboratory analyzers as they prepare to purchase new diagnostic systems. In the case of mid-volume analyzers for immunoassy (IA) and infectious disease (ID) testing, such a report is now available—and it is immediately available on the Web.
The report is titled “Using Quality Management Methods to Compare Competing Mid-Volume Segment Immunoassay Systems that Perform Infectious Disease Testing.” This report can be immediately downloaded and viewed by visiting the darkdaily.com web site.
(more…)
Aug 30, 2010 | Laboratory News, Laboratory Pathology
Comprehensive genetic test database intended for use by pathologists, physicians, researchers and consumers
Pathologists and clinical laboratory managers will soon have a comprehensive registry of genetic tests that they can consult as needed. The National Institutes of Health (NIH) is creating a single public registry with detailed information about both genetic test providers and the 1,600+ genetic tests these providers offer.
The NIH believes the genetic test registry will bring greater transparency to the field. It hopes that the registry creates increased information-sharing about the different genetic tests which are available. Participation in the registry will be voluntary, though groups such as the Genetic Alliance have called for making it mandatory to help weed out what they call “the bad actors” in the industry.
(more…)
Aug 11, 2010 | Laboratory News, Laboratory Pathology
Trend is toward increased use of automation, particularly modular and task-targeted solutions, by medical laboratories across the globe
Worldwide, growing numbers of clinical pathology laboratories and medical laboratories are purchasing total laboratory automation (TLA) systems. This is evidence that the latest generation of laboratory automation products are more robust in use compared to prior years and can be purchased at a price that produces an acceptable return on investment (ROI).
However, the acceptance of total laboratory automation in clinical pathology laboratories is not universal. Only in selected countries have significant numbers of medical laboratories embraced laboratory automation as a way to improve productivity, reduce errors, and boost quality.
(more…)
Aug 2, 2010 | Laboratory News, Laboratory Pathology
Many new in vitro diagnostics companies show their products last week in Anaheim
It’s a troubling fact that most health policymakers in the public and private sectors continue to handle clinical pathology laboratory testing as a commodity. That often translates into health insurance programs paying medical laboratories ever less money for the tests they provide. Under-reimbursement for lab tests is a threat to the integrity of laboratory medicine in this country.
However, two groups in our country think differently than this group of health policymakers. These are patients and Wall Street investors. Individuals in both groups are closely tracking advances in laboratory testing and laboratory medicine that positively affect patient care. They know the clinical and economic benefit of using new clinical lab test technology for the right patient at the right time.
(more…)